Infuse® Bone Graft Lawyers
The Medtronic Infuse® bone graft system is used to promote bone growth in patients undergoing neck and spinal surgeries. The product was approved for use in anterior lumbar fusion surgery. But Infuse also has been used for a number of off-label, or unapproved uses, such as procedures involving the cervical spine—which can lead to irregular bone growth and other serious health problems.
If you or someone you love suffered serious health problems after undergoing surgery in which the Infuse bone graft was used, Ferrer, Poirot & Wansbrough can help. Our Infuse bone graft lawyers want to help you fight for the compensation you deserve for your medical bills, lost wages, and pain and suffering. Contact us anytime—just call (800) 210-8503 or fill out a free initial consultation form.
Serious Infuse® Bone Graft Health Risks
The Infuse bone graft system has been used to treat more than 500,000 patients since its U.S. Food and Drug Administration (FDA) approval in 2002. But the product is now facing increased scrutiny due to risks of severe side effects, including:
- compression of the airway and/or neurological structures in the neck.
- difficulty swallowing, breathing, or speaking.
- infection at the surgical site.
- irregular bone growth.
- nerve pain or damage.
- swollen neck and throat tissue.
The FDA issued a public health notification stating that these complications often arise between two and 14 days after a patient’s surgery and in some cases may require immediate medical intervention or additional corrective surgeries.
Get Experienced Legal Representation
At Ferrer, Poirot & Wansbrough, we’ve been helping injured victims for more than 30 years, and we want to help you, too. You won’t pay out of pocket costs unless our Infuse bone graft lawyers get you money. So don’t wait another day—let us protect your rights to get the compensation you deserve. Give us a call today.
Infuse® is a registered trademark of Medtronic, Inc.
This law firm is not associated with, sponsored by, or affiliated with Medtronic, Inc. or the U.S. Food and Drug Administration.